Accession Number: | 0000899243-20-003379 |
Date: | 2020-02-03 |
Issuer: | WAVE LIFE SCIENCES LTD. (WVE) |
Original Submission Date: |
GAIERO DAVID G
C/O WAVE LIFE SCIENCES LTD.,
733 CONCORD AVE.
CAMBRIDGE, MA 02138
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-02-03 | S | 651 | d | $7.00 | 6,392 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | on february 3, 2020, the reporting person sold 651 ordinary shares solely to cover taxes associated with the vesting of restricted share units on february 1, 2020. these sales were made pursuant to a 10b5-1 trading plan. |
f2 | the price reflected is the weighted-average sale price for shares sold. the shares were sold in multiple transactions and the range of sale prices for the transactions reported was $7.00 to $7.049 per share. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price. |